The Dexcom logo appears on smartphone screens and backgrounds.
Pavlo Gonchar | Sopa Images | Light Rocket | Getty Images
shares Dexcon The diabetes management company fell more than 34% in after-hours trading Thursday after the diabetes management company reported disappointing earnings. second season and provided weak guidance.
Here’s what the company does:
- Earnings per share: Adjusted to 43 cents, compared with LSEG forecast of 39 cents
- income: US$1 billion, compared with LSEG’s forecast of US$1.04 billion
Dexcom’s revenue increased 15% from $871.3 million a year earlier, according to a press release. The company reported net profit of $143.5 million, up from $115.9 million in the same period last year.
Dexcom said it expects third-quarter revenue to be in the range of $975 million to $1 billion, taking into account “certain unique items impacting 2024 seasonality.” Dexcom updated its full fiscal year guidance, reflecting expectations for revenue in the range of $4.0 billion to $4.05, down from the $4.2 billion to $4.35 billion reported last quarter.
“While Dexcom advanced several key strategic initiatives in the second quarter, our execution did not meet our high standards,” Dexcom CEO Kevin Sayer said in the release. “We have a unique opportunity to leverage our differences to With a comprehensive product portfolio serving millions of customers around the world, we are taking actions to improve execution and best position ourselves for continued long-term growth.”
This is breaking news. Please refresh for updates.
About The Author
